Rates of further primary tumours other than contralateral breast cancer are not high, except in TP53 carriers, and very young-onset BRCA1/2 carriers do not seem to be at enhanced risk of ovarian cancer compared with other BRCA1/2 carriers. The gene discussed is TP53; the disease is neoplasm.